'Modern twist' on fertility technique may offer hope for sterile men
By Denis Campbell,
The Guardian
| 11. 02. 2015
Untitled Document
Fourteen babies have been born following the injection of very immature sperm cells into eggs – a technique that could help infertile men to become fathers, scientists say.
The 14 children were born to 12 men and their partners in Japan after round spermatid injection (Rosi), which has been banned in the UK since the 1990s due to concerns for the health of any children it might create.
The disclosure that Japanese scientists have helped previously sterile men to father healthy children using the technique has prompted an expert in male fertility to call for the UK ban to be looked at again.
The method uses spermatids, which are early stage, round-shaped sperm cells that are no more than three-quarters of the way through the normal development process, have no head or tail and do not look like sperm. They can be found in the testes of men who would normally be considered sterile.
In the UK about 1% of British men are infertile because they do not produce sperm. In the Japanese trial the scientists found that...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...